RESUMEN
OBJECTIVE: This study examined the morphological changes in the colonic mucosa and the presence of inflammation in rats induced with 1,2-dimethylhydrazine (DMH) 30 mg/kg BW over 9, 11, and 13 weeks without a latency period. METHODS: Hematoxylin and eosin staining was performed to assess the morphology and characteristic alteration of the epitheliocytes in the colon. Immunohistochemistry was employed to assess the expression of tumor necrosis factor (TNF)-α and cyclooxygenase-2 (COX-2). The difference in the severity of inflammation and COX-2 expression was examined using one-way analysis of variance. The correlation of COX-2 expression with the severity of inflammation was analyzed using Spearman's rank correlation test. RESULT: Until week 13, chronic inflammation and non-hyperplastic and hyperplastic aberrant crypt foci occurred. The severity of inflammation gradually shifted from high moderate to low moderate. TNF-α expression was high in all groups; however, COX-2 expression was gradually lower with longer duration of induction, which corresponded with the severity of inflammation. CONCLUSION: DMH induction until week 13 without a latency period caused chronic inflammation without the formation of adenoma or adenocarcinoma. A very strong correlation was established between COX-2 expression and inflammation.
Asunto(s)
1,2-Dimetilhidrazina , Neoplasias Colorrectales , Ciclooxigenasa 2 , Inflamación , Factor de Necrosis Tumoral alfa , Animales , 1,2-Dimetilhidrazina/toxicidad , Ratas , Neoplasias Colorrectales/patología , Neoplasias Colorrectales/inducido químicamente , Neoplasias Colorrectales/metabolismo , Ciclooxigenasa 2/metabolismo , Inflamación/inducido químicamente , Inflamación/patología , Inflamación/metabolismo , Masculino , Factor de Necrosis Tumoral alfa/metabolismo , Mucosa Intestinal/patología , Mucosa Intestinal/metabolismo , Mucosa Intestinal/efectos de los fármacos , Carcinógenos/toxicidad , Ratas Sprague-Dawley , Focos de Criptas Aberrantes/patología , Focos de Criptas Aberrantes/inducido químicamente , Focos de Criptas Aberrantes/metabolismo , Colon/patología , Colon/metabolismo , Adenocarcinoma/patología , Adenocarcinoma/inducido químicamente , Adenocarcinoma/metabolismoRESUMEN
Selenoproteins play important roles in many cellular functions and biochemical pathways in mammals. Our previous study showed that the deficiency of the 15 kDa selenoprotein (Selenof) significantly reduced the formation of aberrant crypt foci (ACF) in a mouse model of azoxymethane (AOM)-induced colon carcinogenesis. The objective of this study was to examine the effects of Selenof on inflammatory tumorigenesis, and whether dietary selenium modified these effects. For 20 weeks post-weaning, Selenof-knockout (KO) mice and littermate controls were fed diets that were either deficient, adequate or high in sodium selenite. Colon tumors were induced with AOM and dextran sulfate sodium. Surprisingly, KO mice had drastically fewer ACF but developed a similar number of tumors as their littermate controls. Expression of genes important in inflammatory colorectal cancer and those relevant to epithelial barrier function was assessed, in addition to structural differences via tissue histology. Our findings point to Selenof's potential role in intestinal barrier integrity and structural changes in glandular and mucin-producing goblet cells in the mucosa and submucosa, which may determine the type of tumor developing.
Asunto(s)
Focos de Criptas Aberrantes/dietoterapia , Focos de Criptas Aberrantes/metabolismo , Carcinogénesis/efectos de los fármacos , Neoplasias del Colon/sangre , Neoplasias del Colon/dietoterapia , Mucosa Intestinal/metabolismo , Selenoproteínas/metabolismo , Selenito de Sodio/administración & dosificación , Oligoelementos/administración & dosificación , Focos de Criptas Aberrantes/genética , Animales , Azoximetano/efectos adversos , Carcinogénesis/genética , Neoplasias del Colon/inducido químicamente , Neoplasias del Colon/genética , Citocinas/sangre , Sulfato de Dextran/efectos adversos , Dieta/métodos , Modelos Animales de Enfermedad , Regulación Neoplásica de la Expresión Génica/efectos de los fármacos , Mucosa Intestinal/efectos de los fármacos , Masculino , Ratones , Ratones Noqueados , Selenoproteínas/genética , Transducción de Señal/efectos de los fármacos , Transducción de Señal/genéticaRESUMEN
Colorectal cancer (CRC) is the third leading type of adult cancer in both genders with high morbidity and mortality worldwide. Even though the discovery of many antineoplastic drugs for CRC, the current therapy is not adequately efficient.This study was designed to investigate the effect and mechanism of Piclamilast (PIC), a selective PDE4 inhibitor, on a DMH-induced colorectal cancer (CRC) rat model. The rats were grouped (n = 10) into group 1 (control), group 2 (PIC 3 mg/kg, p.o.), groups 3-5 received DMH (20 mg/kg/week, S.C.), and groups 4 and 5 received PIC (1 and 3 mg/kg/day, p.o.) for 15 weeks. The DMH treatment increased aberrant crypt foci (ACF), Proliferating cell nuclear antigen (PCNA), and TBARS levels, along with decreased antioxidant defenses (GSH, GSH-Px, and catalase). Increased NF-κß expression and inflammatory cytokines were also evident. PIC dose-dependently reduced ACF and restored oxidative stress and inflammatory markers favorably. Moreover, PIC in its large, tested dose only significantly increased the intracellular level of cAMP and suppressed the activation of Ras and PI3K and its downstream Akt/mTOR signaling. Furthermore, PIC promoted CRC apoptosis, and increased the gene expression of the apoptotic factors, caspase-3 and Bax, and decreased the anti-apoptotic factor Bcl-2. The results of this study show that PIC may be a promising therapeutic agent for the treatment of CRC. PIC might inhibit the proliferation of CRC cells and induce apoptosis via multiple mechanisms that involve its antioxidant effect and inhibition of NF-κß and Ras/PI3K/Akt/mTOR signaling.
Asunto(s)
1,2-Dimetilhidrazina/antagonistas & inhibidores , 1,2-Dimetilhidrazina/toxicidad , Benzamidas/farmacología , Neoplasias del Colon/tratamiento farmacológico , Neoplasias del Colon/metabolismo , Inhibidores de Fosfodiesterasa 4/farmacología , Piridinas/farmacología , Focos de Criptas Aberrantes/tratamiento farmacológico , Focos de Criptas Aberrantes/metabolismo , Focos de Criptas Aberrantes/patología , Animales , Apoptosis/efectos de los fármacos , Apoptosis/genética , Proliferación Celular/efectos de los fármacos , Neoplasias del Colon/inducido químicamente , Modelos Animales de Enfermedad , Masculino , Estrés Oxidativo/efectos de los fármacos , Fosfatidilinositol 3-Quinasas/metabolismo , Proteínas Proto-Oncogénicas c-akt/metabolismo , Ratas , Ratas Wistar , Transducción de Señal/efectos de los fármacos , Serina-Treonina Quinasas TOR/metabolismo , Proteínas ras/metabolismoRESUMEN
BACKGROUND: Colorectal cancer is a highly prevalent disease, requiring effective strategies for prevention and treatment. The present research aimed to formulate a natural fiber-rich food product (NFRFP) and to evaluate its safety, toxicogenetics, and effects on aberrant crypt foci induced by 1,2-dimethyl-hydrazine in a preclinical model. METHODS: A total of 78 male Wistar rats were distributed in six experimental groups: negative control, positive control (1,2-Dimethylhydrazine-40 mg/Kg), and four groups fed with 10% NFRFP: NFRFP, pre-treatment protocol, simultaneous treatment, and post-treatment protocol. RESULTS: The NFRFP was shown to be a good source of fibers and did not change biometric, biochemical, hematological, and inflammatory parameters, and did not induce signs of toxicity and genotoxicity/carcinogenicity. NFRFP exhibited a chemopreventive effect, in all protocols, with damage reduction (% DR) of 75% in the comet test. NFRFP reduced the incidence of aberrant crypt outbreaks by 49.36% in the post-treatment protocol. CONCLUSIONS: The results suggest the applicability of NFRFP in the human diet due to potential production at an industrial scale and easy technological application in different products, since it could be incorporated in food without altering or causing small changes in final product sensory characteristics.
Asunto(s)
Focos de Criptas Aberrantes/prevención & control , Colon/patología , Neoplasias Colorrectales/prevención & control , Fibras de la Dieta/administración & dosificación , 1,2-Dimetilhidrazina , Focos de Criptas Aberrantes/inducido químicamente , Focos de Criptas Aberrantes/metabolismo , Focos de Criptas Aberrantes/patología , Alimentación Animal , Animales , Colon/metabolismo , Neoplasias Colorrectales/inducido químicamente , Neoplasias Colorrectales/metabolismo , Neoplasias Colorrectales/patología , Citocinas/sangre , Modelos Animales de Enfermedad , Mediadores de Inflamación/sangre , Masculino , Ratas WistarRESUMEN
Ethanolamine plasmalogen (PlsEtn), a sub-class of ethanolamine glycerophospholipids (EtnGpl), is a universal phospholipid in mammalian membranes. Several researchers are interested in the relationship between colon carcinogenesis and colon PlsEtn levels. Here, we evaluated the functional role of dietary purified EtnGpl from the ascidian muscle (87.3 mol% PlsEtn in EtnGpl) and porcine liver (7.2 mol% PlsEtn in EtnGpl) in 1,2-dimethylhydrazine (DMH)-induced aberrant crypt foci (ACF) in vivo, and elucidated the possible underlying mechanisms behind it. Dietary EtnGpl-suppressed DMH-induced aberrant crypt with one foci (AC1) and total ACF formation (P < 0.05). ACF suppression by dietary ascidian muscle EtnGpl was higher compared with dietary porcine liver EtnGpl. Additionally, dietary EtnGpl decreased DMH-induced oxidative damage, overproduction of TNF-α, and expression of apoptosis-related proteins in the colon mucosa. The effect of dietary ascidian muscle EtnGpl showed superiority compared with dietary porcine liver EtnGpl. Our results demonstrate the mechanisms by which dietary PlsEtn suppress ACF formation and apoptosis. Dietary PlsEtn attained this suppression by reducing colon inflammation and oxidative stress hence a reduction in DMH-induced intestinal impairment. These findings provide new insights about the functional role of dietary PlsEtn during colon carcinogenesis.
Asunto(s)
Focos de Criptas Aberrantes/metabolismo , Carcinogénesis/efectos de los fármacos , Colon/efectos de los fármacos , Inflamación/tratamiento farmacológico , Plasmalógenos/farmacología , Compuestos de Vinilo/farmacología , 1,2-Dimetilhidrazina/antagonistas & inhibidores , Focos de Criptas Aberrantes/inducido químicamente , Animales , Apoptosis/efectos de los fármacos , Carcinogénesis/metabolismo , Colon/metabolismo , Colon/patología , Exposición Dietética , Inflamación/inducido químicamente , Inflamación/metabolismo , Hígado/química , Músculos/química , Estrés Oxidativo/efectos de los fármacos , Plasmalógenos/administración & dosificación , Porcinos , Urocordados , Compuestos de Vinilo/administración & dosificaciónRESUMEN
Glucosylceramide (GlcCer), a major sphingolipid in plants and fungi, is known to have food functions, such as preventing intestinal impairment and enhancing the moisture content of skin. This study investigated the influence of fermentation on the composition and function of lipophilic components containing GlcCer in plant-based foods; we compared the effects of ethanol extracts from sake rice (SR) and sake lees (SL) on colon impairment in mice. GlcCer and ceramide (Cer) levels in SL were much higher than those in SR, and GlcCer in SL contained 9-methyl-trans-4,trans-8-sphingadienine as a fungi-specific sphingoid base. 1,2-dimethylhydrazine (DMH) treatment markedly increased the formation of aberrant crypt foci (ACF) and the levels of TNF-α and lipid oxidation in mice colons. However, dietary SR or SL significantly suppressed these DMH-induced changes, and SR demonstrated stronger effects than SL. In addition, dietary SR or SL suppressed the expression of apoptotic and anti-apoptotic proteins induced by DMH treatment. This study suggests that SR or SL intake could reduce colon ACF formation via the suppression of inflammation and oxidation-induced cell cycle disturbances. When compared to SR, the weaked effects of SL rich in GlcCer may be the result of the changes in sphingolipid composition (sphingoid base and Cer) and differences in the concentration of other bioactive compounds produced or digested during fermentation.
Asunto(s)
Focos de Criptas Aberrantes/prevención & control , Neoplasias del Colon/prevención & control , Glucosilceramidas/análisis , Glucosilceramidas/farmacología , Oryza/química , Fitoterapia , Extractos Vegetales/análisis , Extractos Vegetales/farmacología , Vino/análisis , Focos de Criptas Aberrantes/metabolismo , Focos de Criptas Aberrantes/patología , Administración Oral , Animales , Apoptosis , Neoplasias del Colon/metabolismo , Neoplasias del Colon/patología , Modelos Animales de Enfermedad , Etanol , Femenino , Fermentación , Glucosilceramidas/administración & dosificación , Humanos , Peroxidación de Lípido/efectos de los fármacos , Ratones Endogámicos BALB C , Extractos Vegetales/administración & dosificación , Factor de Necrosis Tumoral alfa/metabolismoRESUMEN
There is strong evidence that foods containing dietary fibre protect against colorectal cancer, resulting at least in part from its anti-proliferative properties. This study aimed to investigate the effects of supplementation with two non-digestible carbohydrates, resistant starch (RS) and polydextrose (PD), on crypt cell proliferative state (CCPS) in the macroscopically normal rectal mucosa of healthy individuals. We also investigated relationships between expression of regulators of apoptosis and of the cell cycle on markers of CCPS. Seventy-five healthy participants were supplemented with RS and/or PD or placebo for 50 d in a 2 × 2 factorial design in a randomised, double-blind, placebo-controlled trial (the Dietary Intervention, Stem cells and Colorectal Cancer (DISC) Study). CCPS was assessed, and the expression of regulators of the cell cycle and of apoptosis was measured by quantitative PCR in rectal mucosal biopsies. SCFA concentrations were quantified in faecal samples collected pre- and post-intervention. Supplementation with RS increased the total number of mitotic cells within the crypt by 60 % (P = 0·001) compared with placebo. This effect was limited to older participants (aged ≥50 years). No other differences were observed for the treatments with PD or RS as compared with their respective controls. PD did not influence any of the measured variables. RS, however, increased cell proliferation in the crypts of the macroscopically-normal rectum of older adults. Our findings suggest that the effects of RS on CCPS are not only dose, type of RS and health status-specific but are also influenced by age.
Asunto(s)
Proliferación Celular/efectos de los fármacos , Suplementos Dietéticos , Glucanos/farmacología , Mucosa Intestinal/citología , Recto/citología , Almidón/farmacología , Focos de Criptas Aberrantes/metabolismo , Adulto , Anciano , Anciano de 80 o más Años , Neoplasias del Colon/metabolismo , Método Doble Ciego , Heces/química , Femenino , Voluntarios Sanos , Humanos , Masculino , Persona de Mediana EdadRESUMEN
This study aimed to investigate the underlying mechanisms in anti-tumorigenesis effects of exercise through evaluation of inflammation and apoptosis. Twenty-four Wistar rats were divided into control, exercise, 1,2-dimethylhydrazine (DMH), and DMH + exercise. After a week, rats in the DMH group were given DMH twice a week for 2 weeks. Animals in the exercise groups performed exercise on a treadmill 5 days/week for 8 weeks. After 8 weeks of training, levels of COX-2, PCNA, Bax, Bcl-2, and procaspase-3/cleaved caspase-3 were assessed. Histological changes, number of aberrant crypt foci (ACF), and serum levels of TNF-α and IL-6 were also analyzed. ACF number was significantly decreased following the exercise program. Protein levels of COX-2 and PCNA and serum levels of IL-6 and TNF-α were significantly elevated in the rats receiving DMH and downregulated after performing the exercise program (P < 0.05). Exercise upregulated apoptosis, which was evident from the increased Bax/Bcl2 ratio, and enhanced the expression levels of activated caspase-3 as compared to the DMH group. The colonic architecture was improved in DMH + exercise. Exercise can effectively attenuate DMH-induced increase of inflammatory markers. Exercise induces apoptosis at the downstream of the inflammatory response. Therefore, exercise may play a role as a moderator of inflammation to exert protective effects against colon cancer.
Asunto(s)
1,2-Dimetilhidrazina/toxicidad , Focos de Criptas Aberrantes/terapia , Proteínas Reguladoras de la Apoptosis/metabolismo , Neoplasias Colorrectales/terapia , Mediadores de Inflamación/metabolismo , Inflamación/prevención & control , Condicionamiento Físico Animal , Focos de Criptas Aberrantes/inducido químicamente , Focos de Criptas Aberrantes/metabolismo , Focos de Criptas Aberrantes/patología , Animales , Apoptosis , Carcinógenos/toxicidad , Neoplasias Colorrectales/inducido químicamente , Neoplasias Colorrectales/metabolismo , Neoplasias Colorrectales/patología , Inflamación/etiología , Inflamación/metabolismo , Inflamación/patología , Masculino , Ratas , Ratas WistarRESUMEN
Falcarinol (FaOH) and falcarindiol (FaDOH) are cytotoxic and anti-inflammatory polyacetylenic oxylipins, which are commonly found in the carrot family (Apiaceae). FaOH and FaDOH have previously demonstrated a chemopreventive effect on precursor lesions of colorectal cancer (CRC) in azoxymethane (AOM)-induced rats. The purpose of the present study was to elucidate possible mechanisms of action for the preventive effect of FaOH and FaDOH on colorectal precancerous lesions and to determine how this effect was dependent on dose. Gene expression studies performed by RT-qPCR of selected cancer biomarkers in tissue from biopsies of neoplastic tissue revealed that FaOH and FaDOH downregulated NF-κß and its downstream inflammatory markers TNFα, IL-6, and COX-2. The dose-dependent anti-neoplastic effect of FaOH and FaDOH in AOM-induced rats was investigated in groups of 20 rats receiving a standard rat diet (SRD) supplemented with 0.16, 0.48, 1.4, 7 or 35 µg FaOH and FaDOH g-1 feed in the ratio 1:1 and 20 rats were controls receiving only SRD. Analysis of aberrant crypt foci (ACF) showed that the average number of small ACF (<7 crypts) and large ACF (>7 crypts) decreased with increasing dose of FaOH and FaDOH and that this inhibitory effect on early neoplastic formation of ACF was dose-dependent, which was also the case for the total number of macroscopic neoplasms. The CRC protective effects of apiaceous vegetables are mainly due to the inhibitory effect of FaOH and FaDOH on NF-κB and its downstream inflammatory markers, especially COX-2.
Asunto(s)
Antineoplásicos , Neoplasias Colorrectales , Diinos , Alcoholes Grasos , Focos de Criptas Aberrantes/metabolismo , Focos de Criptas Aberrantes/patología , Focos de Criptas Aberrantes/prevención & control , Animales , Antiinflamatorios/administración & dosificación , Antiinflamatorios/farmacología , Antineoplásicos/administración & dosificación , Antineoplásicos/farmacología , Colon/efectos de los fármacos , Colon/metabolismo , Colon/patología , Neoplasias Colorrectales/metabolismo , Neoplasias Colorrectales/patología , Neoplasias Colorrectales/prevención & control , Citocinas/metabolismo , Diinos/administración & dosificación , Diinos/farmacología , Alcoholes Grasos/administración & dosificación , Alcoholes Grasos/farmacología , Regulación Neoplásica de la Expresión Génica/efectos de los fármacos , Inflamación/metabolismo , Inflamación/prevención & control , Masculino , Neoplasias Experimentales/metabolismo , Neoplasias Experimentales/patología , Neoplasias Experimentales/prevención & control , Ratas , Ratas Endogámicas F344 , Transducción de Señal/efectos de los fármacosRESUMEN
Glucosylceramide (GlcCer), a major sphingolipid in plants and fungi, is known to have food functions such as preventing intestinal impairment and enhancing the moisture content of skin. However, there is little information about functions of GlcCer in food sources as most of the studies on GlcCer functions are done using purified GlcCer. This study was performed to investigate the effects of GlcCer contained in food on intestinal impairment; polished rice flour (RF) and this ethanol extract (RE) were used as sources of GlcCer, and these were evaluated by studying the formation of aberrant crypt foci (ACF) in 1,2-dimethylhydrazine (DMH)-treated mice, which is a model of colon cancer. Mice were fed with either a control diet, a RF diet where RF replaces cornstarch (150 g/kg), or a plus RE diet (0.5 g/kg; RE was extracted from the same amount of RF present in the RF diet). The amount of GlcCer was similar in both the RF and RE diets (3.0 and 2.7 mg/kg, respectively). DMH treatment induced the formation of ACF and the production of inflammation-related cytokines. Both dietary RF and RE suppressed ACF formation and RE, in particular, showed a significant suppressive effect. Dietary RE inhibited the production of almost all of the inflammation-related cytokines studied, while RF suppressed only a few of these cytokines. The present study suggests that the lipophilic fraction including GlcCer, present in polished rice has protective effects against intestinal impairment, but it requires extraction since digestion alone is not enough to elicit its complete protective action.
Asunto(s)
Focos de Criptas Aberrantes/prevención & control , Neoplasias del Colon/prevención & control , Glucosilceramidas/administración & dosificación , Oryza/química , Fitoterapia , Extractos Vegetales/administración & dosificación , Focos de Criptas Aberrantes/metabolismo , Animales , Antineoplásicos Fitogénicos , Neoplasias del Colon/metabolismo , Citocinas/metabolismo , Modelos Animales de Enfermedad , Glucosilceramidas/farmacología , Mediadores de Inflamación/metabolismo , Extracción Líquido-Líquido/métodos , Masculino , Ratones Endogámicos BALB C , Extractos Vegetales/química , Extractos Vegetales/farmacologíaRESUMEN
The incidence of colorectal cancer (CRC) has been on the rise, which is linked to the increasing prevalence of obesity, based on global epidemiological evidence. Although chronic inflammation is implicated in tumor development, the mechanisms underlying obesity-associated CRC remain unknown. Here, we sought to identify the inflammatory cytokines and their roles in obesity-related colorectal tumorigenesis using cytokine array analyses in a mouse model. Colorectal tumorigenesis was induced through i.p. injection of azoxymethane once a week for 6 weeks in 6-week-old female WT C57Black/6J mice and the obesity diabetes model mouse KK/TaJcl, KK-Ay/TaJcl. The formation of aberrant crypt foci and colorectal tumors were more frequent in obese mice compared with WT mice, and both serum interleukin (IL)-13 and IL-13 receptor (R) expression in the normal intestinal mucosal epithelium were significantly increased in the obese mice. Furthermore, addition of IL-13 to a human CRC cell line and a human colon organoid culture altered the phenotype of intestinal epithelial cells. Knockdown experiments further revealed that IL-13Rα1 dominantly induced mucosal proliferation. Collectively, These results suggest an association between anti-inflammatory cytokines and colorectal carcinogenesis, and provide new research directions for cancer prevention strategies. In particular, inflammation provoked by obesity, notably by increased expression of the cytokine IL-13, could play an important role in the carcinogenesis of obesity-related CRC.
Asunto(s)
Focos de Criptas Aberrantes/patología , Azoximetano/efectos adversos , Neoplasias Colorrectales/patología , Interleucina-13/sangre , Obesidad/complicaciones , Regulación hacia Arriba , Focos de Criptas Aberrantes/inducido químicamente , Focos de Criptas Aberrantes/metabolismo , Animales , Azoximetano/administración & dosificación , Proliferación Celular , Neoplasias Colorrectales/inducido químicamente , Neoplasias Colorrectales/inmunología , Modelos Animales de Enfermedad , Femenino , Regulación Neoplásica de la Expresión Génica , Células HT29 , Humanos , Ratones , Ratones Endogámicos C57BL , Obesidad/inmunología , Absorción Peritoneal , Receptores de Interleucina-13/sangre , Transducción de SeñalRESUMEN
Zinc is a trace element widely known for its marked antioxidant properties. To gain more insight into the site- and time- specific mechanisms by which it induces chemoprevention, this study was elaborated over a pre-cancerous model of colon carcinogenesis. Colon cancer was induced by 1,2-dimethylhydrazine (DMH) in mice (20â¯mg/kg for 2 weeks) and groups of animals were supplemented with or without zinc sulfate (ZnSO4, 200â¯mg/L) in drinking water for 4, 10 or 14 weeks. Colon tissues were collected for pathological observation, analyzing aberrant crypt (AC) and aberrant crypt foci (ACF) formations, multiplicity and distribution. Similarly, histological assessment and mucin production, as well as oxidative stress markers estimation was performed for the different groups. Results showed a significant increase in ACF and AC numbers, ACF multiplicity and demonstrated stronger distal occurrence than in the proximal after DHM administration. Histopathological analysis presented marked structural alterations and mucin loss in the distal than the proximal colons. A significant increase in myeloperoxidase (MPO), nitric oxide (NO), L-ornithine and malondialdehyde (MDA) levels was observed followed by a significant decrease in antioxidant markers (superoxide dismutase (SOD), catalase (CAT) and reduced glutathione (GSH)). Oral ZnSO4 supplementation (continuous or partial) induced significant decrease in ACF, AC numbers and multiplicity, restored histological architecture and mucin production, and a significant decrease in proinflammatory markers while it reduced antioxidants to normal levels. From this study, insight was obtained on the use of ZnSO4 as a chemopreventive agent and shed light on its potential, as a supplement in nutraceutical approaches.
Asunto(s)
Focos de Criptas Aberrantes/tratamiento farmacológico , Neoplasias del Colon/tratamiento farmacológico , Sulfato de Zinc/farmacología , 1,2-Dimetilhidrazina/toxicidad , Focos de Criptas Aberrantes/inducido químicamente , Focos de Criptas Aberrantes/metabolismo , Animales , Anticarcinógenos/farmacología , Antioxidantes/metabolismo , Neoplasias del Colon/inducido químicamente , Neoplasias del Colon/metabolismo , Enzimas/metabolismo , Ratones , Neoplasias Experimentales/inducido químicamente , Estrés Oxidativo/efectos de los fármacos , Lesiones Precancerosas/inducido químicamente , Lesiones Precancerosas/tratamiento farmacológico , Lesiones Precancerosas/patologíaRESUMEN
Colon cancer is thought to develop in a stepwise fashion. In this study, the relationship between aberrant crypt foci (ACF) regional distribution and oxidative stress evolution was studied in a murine model of initial colon carcinogenesis induced by dimethylhydrazine (DMH). Mice were given 2 weekly subcutaneous injections of DMH (20 mg/kg) and killed at the 10th, 12th or 14th week. ACF was scored for number, distribution and crypt multiplicity after methylene-blue coloration and histologically analyzed afterwards. Oxidative stress evaluation was assessed through myeloperoxidase activity (MPO), nitric oxide (NO), L-ornithine and malondialdehyde (MDA) levels as well as antioxidant CAT, SOD and GSH. DMH treatment showed a shift from small to large ACF but also from distal to proximal colon between week 10 and 14 (p < 0.05). This was further illustrated histologically with crypt disruption and mucin depletion. Oxidative stress imbalance was observed in all DMH-treated groups. All markers (MPO, MDA and NO) peaked at week 12 (p < 0.01) and decreased at week 14 (p < 0.05) while L-ornithine decreased through all protocol (p < 0.01). Antioxidants decreased in all points (p < 0.05) but only GSH increased at week 14 (p < 0.05). This work provided insight to response-patterns of oxidative stress between distal and proximal colon, showing for the first time a decreasing implication during the development process and suggesting other inflammatory, immunologic or microbiota implication as factors to be considered during chemotherapy approaches.
Asunto(s)
1,2-Dimetilhidrazina/farmacología , Focos de Criptas Aberrantes/inducido químicamente , Carcinogénesis/efectos de los fármacos , Neoplasias del Colon/inducido químicamente , Estrés Oxidativo/efectos de los fármacos , Focos de Criptas Aberrantes/metabolismo , Animales , Antioxidantes/metabolismo , Biomarcadores de Tumor/metabolismo , Colon/efectos de los fármacos , Colon/metabolismo , Neoplasias del Colon/metabolismo , Modelos Animales de Enfermedad , Femenino , Malondialdehído/metabolismo , Ratones , Mucinas/metabolismo , Óxido Nítrico/metabolismo , Ornitina/metabolismo , Peroxidasa/metabolismoRESUMEN
Colorectal Cancer (CRC) is the third most frequent type of cancer worldwide. In the past few years, studies have revealed a protective effect of metformin (MET-an anti-hyperglycemic drug, used to treat type 2 diabetes), against CRC. The protective effect of MET has been associated with AMPK activation (and mTOR inhibition), resulting in suppressed protein synthesis, and reduced cell proliferation in malignant transformed cells. To elucidate new mechanisms for the protective effect of metformin, we evaluated the oxidative stress and inflammatory process modulation, since these processes are strictly involved in colorectal carcinogenesis. The present study evaluated the protective effect of MET in a CRC model induced by 1,2-dimethylhydrazine (DMH) in Balb/c female mice. The simultaneous/continuous treatment (administration of MET and DMH simultaneously), revealed protective activity of MET, preventing the formation of aberrant crypt foci (ACF) in 71.4% at distal colon sections, and was able to restore basal labeling of apoptosis. Treatment with MET also reduced the inflammatory process induced by DMH, resulting in of the reduction of oxidative stress and nitric oxide related parameters. © 2016 Wiley Periodicals, Inc.
Asunto(s)
1,2-Dimetilhidrazina/toxicidad , Focos de Criptas Aberrantes/prevención & control , Neoplasias Colorrectales/prevención & control , Metformina/administración & dosificación , Proteínas Quinasas Activadas por AMP/metabolismo , Focos de Criptas Aberrantes/inducido químicamente , Focos de Criptas Aberrantes/inmunología , Focos de Criptas Aberrantes/metabolismo , Animales , Proliferación Celular/efectos de los fármacos , Neoplasias Colorrectales/inducido químicamente , Neoplasias Colorrectales/inmunología , Neoplasias Colorrectales/metabolismo , Femenino , Metformina/farmacología , Ratones , Neoplasias Experimentales , Estrés Oxidativo/efectos de los fármacos , Transducción de Señal/efectos de los fármacos , Resultado del TratamientoRESUMEN
The majority of colon tumors are driven by aberrant Wnt signaling in intestinal stem cells, which mediates an efficient route toward initiating intestinal cancer. Natural lipophilic polyphenols and long-chain polyunsaturated fatty acids (PUFAs) generally suppress Wnt- and NF-κB- (nuclear factor-κ light-chain enhancer of activated B-cell) related pathways. However, the effects of these extrinsic agents on colonic leucine-rich repeat-containing G-protein-coupled receptor 5-positive (Lgr5+) stem cells, the cells of origin of colon cancer, have not been documented to date. Therefore, we examined the effect of n-3 PUFA and polyphenol (curcumin) combination on Lgr5+ stem cells during tumor initiation and progression in the colon compared with an n-6 PUFA-enriched control diet. Lgr5-EGFP-IRES-creERT2 knock-in mice were fed diets containing n-6 PUFA (control), n-3 PUFA, n-6 PUFA+curcumin or n-3 PUFA+curcumin for 3 weeks, followed by 6 azoxymethane (AOM) injections, and terminated 17 weeks after the last injection. To further elucidate the effects of the dietary bioactives at the tumor initiation stage, Lgr5+ stem cells were also assessed at 12 and 24 h post AOM injection. Only n-3 PUFA+curcumin feeding reduced nuclear ß-catenin in aberrant crypt foci (by threefold) compared with control at the progression time point. n-3 PUFA+curcumin synergistically increased targeted apoptosis in DNA-damaged Lgr5+ stem cells by 4.5-fold compared with control at 12 h and maximally reduced damaged Lgr5+ stem cells at 24 h, down to the level observed in saline-treated mice. Finally, RNAseq analysis indicated that p53 signaling in Lgr5+ stem cells from mice exposed to AOM was uniquely upregulated only following n-3 PUFA+curcumin cotreatment. These novel findings demonstrate that Lgr5+ stem cells are uniquely responsive to external dietary cues following the induction of DNA damage, providing a therapeutic strategy for eliminating damaged Lgr5+ stem cells to reduce colon cancer initiation.
Asunto(s)
Ciclo Celular , Neoplasias del Colon/patología , Dieta , Receptores Acoplados a Proteínas G/metabolismo , Células Madre/citología , Focos de Criptas Aberrantes/metabolismo , Animales , Apoptosis/efectos de los fármacos , Azoximetano , Carcinogénesis/efectos de los fármacos , Carcinogénesis/metabolismo , Carcinogénesis/patología , Carcinógenos , Ciclo Celular/efectos de los fármacos , Diferenciación Celular/efectos de los fármacos , Núcleo Celular/efectos de los fármacos , Núcleo Celular/metabolismo , Quimioprevención , Colon/efectos de los fármacos , Colon/metabolismo , Colon/patología , Neoplasias del Colon/metabolismo , Curcumina/farmacología , Roturas del ADN de Doble Cadena/efectos de los fármacos , Metilasas de Modificación del ADN/metabolismo , Enzimas Reparadoras del ADN/metabolismo , Ácidos Grasos Omega-3 , Aceites de Pescado/farmacología , Proteínas Fluorescentes Verdes/metabolismo , Ratones , Regeneración/efectos de los fármacos , Factores de Riesgo , Transducción de Señal/efectos de los fármacos , Células Madre/efectos de los fármacos , Células Madre/metabolismo , Fracciones Subcelulares/efectos de los fármacos , Fracciones Subcelulares/metabolismo , Proteína p53 Supresora de Tumor/metabolismo , Proteínas Supresoras de Tumor/metabolismo , beta Catenina/metabolismoRESUMEN
The selectivity and beneficial effects of prebiotics are mainly dependent on composition and glycosidic linkage among monosaccharide units. This is the first study to use prebiotic galacto-oligosaccharides (GOS) that contains ß-1,6 and ß-1,3 glycosidic linkages and the novel combination of GOS and inulin in cancer prevention. The objective of the present study is to explore the role of novel GOS and inulin against various biomarkers of colorectal cancer (CRC) and the incidence of aberrant crypt foci (ACF) in a 1,2-dimethyl hydrazine dihydrochloride (DMH)-induced rodent model. Prebiotic treatments of combined GOS and inulin (57 mg each), as well as individual doses (GOS: 76-151 mg; inulin 114 mg), were given to DMH-treated animals for 16 weeks. Our data reveal the significant preventive effect of the GOS and inulin combination against the development of CRC. It was observed that inhibition of ACF formation (55.8%) was significantly (p ≤ 0.05) higher using the GOS and inulin combination than GOS (41.4%) and inulin (51.2%) treatments alone. This combination also rendered better results on short-chain fatty acids (SCFA) and bacterial enzymatic activities. Dose-dependent effects of prebiotic treatments were also observed on cecum and fecal bacterial enzymes and on SCFA. Thus, this study demonstrated that novel combination of GOS and inulin exhibited stronger preventive activity than their individual treatments alone, and can be a promising strategy for CRC chemoprevention.
Asunto(s)
Focos de Criptas Aberrantes/prevención & control , Anticarcinógenos/uso terapéutico , Neoplasias del Colon/prevención & control , Modelos Animales de Enfermedad , Inulina/uso terapéutico , Prebióticos , Trisacáridos/uso terapéutico , 1,2-Dimetilhidrazina , Focos de Criptas Aberrantes/metabolismo , Focos de Criptas Aberrantes/microbiología , Focos de Criptas Aberrantes/patología , Amoníaco/análisis , Animales , Anticarcinógenos/administración & dosificación , Proteínas Bacterianas/metabolismo , Biomarcadores de Tumor/análisis , Biomarcadores de Tumor/metabolismo , Ciego/enzimología , Ciego/metabolismo , Ciego/microbiología , Colon/metabolismo , Colon/microbiología , Colon/patología , Neoplasias del Colon/metabolismo , Neoplasias del Colon/microbiología , Neoplasias del Colon/patología , Ácidos Grasos Volátiles/análisis , Ácidos Grasos Volátiles/metabolismo , Heces/química , Heces/enzimología , Heces/microbiología , Concentración de Iones de Hidrógeno , Mucosa Intestinal/metabolismo , Mucosa Intestinal/microbiología , Mucosa Intestinal/patología , Inulina/administración & dosificación , Masculino , Distribución Aleatoria , Ratas Wistar , Estereoisomerismo , Trisacáridos/administración & dosificación , Trisacáridos/químicaRESUMEN
Colorectal cancer (CRC) is a major cause of morbidity and mortality throughout the world, with chronic inflammation and diet as major causes in its development. Chemopreventive effects of natural dietary products have been the focus of studies for prevention over the past decade. This study was conducted to determine the effects of unpolished Thai rice during precancerous stage through the involvement of ?catenin, cyclooxygenase2 (COX2) expression and inflammatory cytokines focusing on azoxymethane (AOM)induced aberrant crypt foci (ACF)related to CRC. Male Sprague Dawley rats received two injections of AOM (15 mg/kg body weight) at weeks 4 and 5 while rats were treated with 20% or 70% unpolished Thai rice. The rats were sacrificed at week 38 and the colons removed for aberrant crypt foci (ACF) identification. Histopathologic changes, immunohistochemical analysis of ?catenin and COX2 expression, and cytokine expression of proinflammatory and antiinflammatory markers were determined. The administration of unpolished Thai rice significantly and dose dependently decreased the total number of ACF and the percentages of ACF with highgrade dysplasia. Interestingly, unpolished Thai rice suppressed the expression of ßcatenin and COX2. In addition, it also altered proinflammatory (IL6 and IFNγ) and antiinflammatory (IL 10) markers. The results suggested that unpolished Thai rice may provide a promising dietary intake for prevention during precancerous stage of CRC development, through the involvement of ßcatenin and COX2 expression, and also modulate inflammatory cytokinesrelated to CRC.
Asunto(s)
Focos de Criptas Aberrantes/prevención & control , Anticarcinógenos/administración & dosificación , Azoximetano/farmacología , Cateninas/metabolismo , Neoplasias Colorrectales/prevención & control , Ciclooxigenasa 2/metabolismo , Oryza , Focos de Criptas Aberrantes/inducido químicamente , Focos de Criptas Aberrantes/metabolismo , Animales , Biomarcadores/metabolismo , Quimioprevención/métodos , Neoplasias Colorrectales/inducido químicamente , Neoplasias Colorrectales/metabolismo , Inflamación/inducido químicamente , Inflamación/metabolismo , Interferón gamma/metabolismo , Interleucina-10/metabolismo , Interleucina-6/metabolismo , Masculino , Lesiones Precancerosas/metabolismo , Lesiones Precancerosas/prevención & control , Ratas , Ratas Sprague-Dawley , TailandiaRESUMEN
Dietary fiber has been reported to prevent preneoplastic colon lesions. The aim of this study was to determine the effect of resistant starches, novel dietary fibers, on the development of colonic preneoplasia and Wnt signaling in azoxymethane (AOM)-treated rats and mice fed resistant starches at 55% of the diet after AOM treatment. Another objective was to determine the effect of resistant starches on the development of preneoplasia in rats treated with antibiotics (Ab), administered between AOM treatment and resistant starch feeding. Diets containing resistant starches, high-amylose (HA7), high-amylose-octenyl succinic anhydride (OS-HA7), or high-amylose-stearic acid (SA-HA7) were compared with control cornstarch (CS). The resistant starch content of the diets did not alter the yield of colonic lesions but animals treated with AOM and fed the diet with the highest resistant starch content, SA-HA7 developed the highest average aberrant crypt foci (ACF) per animal. Mice fed the OS-HA7 diet had decreased expression of some upstream Wnt genes in the colonic crypts. This study suggests that further research is needed to determine if resistant starch impacts colon carcinogenesis in rodents.
Asunto(s)
Anticarcinógenos/uso terapéutico , Neoplasias del Colon/prevención & control , Prebióticos , Lesiones Precancerosas/prevención & control , Almidón/uso terapéutico , Vía de Señalización Wnt , Focos de Criptas Aberrantes/metabolismo , Focos de Criptas Aberrantes/microbiología , Focos de Criptas Aberrantes/patología , Focos de Criptas Aberrantes/prevención & control , Animales , Antibacterianos/efectos adversos , Anticarcinógenos/metabolismo , Azoximetano/toxicidad , Carcinógenos/toxicidad , Colon/efectos de los fármacos , Colon/metabolismo , Colon/microbiología , Neoplasias del Colon/metabolismo , Neoplasias del Colon/microbiología , Neoplasias del Colon/patología , Microbioma Gastrointestinal/efectos de los fármacos , Regulación Neoplásica de la Expresión Génica/efectos de los fármacos , Mucosa Intestinal/efectos de los fármacos , Mucosa Intestinal/metabolismo , Mucosa Intestinal/microbiología , Ratones Endogámicos A , Proteínas de Neoplasias/genética , Proteínas de Neoplasias/metabolismo , Lesiones Precancerosas/metabolismo , Lesiones Precancerosas/microbiología , Lesiones Precancerosas/patología , Ratas Endogámicas F344 , Almidón Resistente , Almidón/análogos & derivados , Almidón/metabolismo , Ácidos Esteáricos/metabolismo , Ácidos Esteáricos/uso terapéutico , Anhídridos Succínicos/metabolismo , Anhídridos Succínicos/uso terapéutico , Carga Tumoral/efectos de los fármacos , Vía de Señalización Wnt/efectos de los fármacosRESUMEN
The aim of this study was to investigate the efficacy of a Berberis integerrima hydroalcoholic extract as a chemotherapeutic agent in colon carcinogenesis in the rat induced by 1,2-dimethyl hydrazine (DMH). Male Wistar rats were divided into five groups: a negative control group without DMH treatment; a control group injected DMH (20 mg/kg b.w); two groups receiving B. integerrima extract (50 and 100 mg/kg b.w), concomitant with injected DMH, as chemotherapeutic groups; a positive control group receiving 5-fluorouracil (5-FU) along with DMH. The effects of the extracts were determined by assessment of hepatic malondialdehyde (MDA), glutathione (GSH), ferric reducing ability of plasma (FRAP), and the activities of hepatic glutathione S-transferase and cytochrome P450 (GST and CYP450). Additionally, colon tissues were assessed for colonic ß-catenin and histopathological analysis. In DMH-treated rats, the extracts partially normalized the levels of FRAP, CYP450, ß-catenin, and GST. Likewise, formation of aberrant crypt foci (ACF) in colon tissue of DMH-treated was reduced by the extracts. Thus, the extracts possess chemotherapeutic activity against colon carcinogenesis.
Asunto(s)
Berberis/química , Neoplasias del Colon/tratamiento farmacológico , Modelos Animales de Enfermedad , Extractos Vegetales/farmacología , 1,2-Dimetilhidrazina , Focos de Criptas Aberrantes/tratamiento farmacológico , Focos de Criptas Aberrantes/metabolismo , Animales , Carcinógenos , Colon/efectos de los fármacos , Colon/metabolismo , Colon/patología , Neoplasias del Colon/inducido químicamente , Neoplasias del Colon/metabolismo , Sistema Enzimático del Citocromo P-450/metabolismo , Etanol/química , Glutatión/metabolismo , Glutatión Transferasa/metabolismo , Hígado/efectos de los fármacos , Hígado/metabolismo , Hígado/patología , Masculino , Malondialdehído/metabolismo , Fitoterapia , Extractos Vegetales/química , Ratas Wistar , Resultado del Tratamiento , Agua/química , beta Catenina/metabolismoRESUMEN
BACKGROUND: 2,5-dimethylfuran (DMF) is formed during heating of foods. Following side chain hydroxylation, DMF could be a substrate for human sulphotransferases (SULTs), which may lead to formation of a DNA reactive electrophile. Only few conflicting in vitro and no in vivo studies on DMF currently exist. MATERIALS AND METHODS: The tumorigenic potential of DMF was studied in multiple intestinal neoplasia Apc(Min/+) (Min) mice that are sensitive to intestinal carcinogenesis and express hSULTs 1A1 and 1A2 (Min/hSULT). Min and Min/hSULT mice were orally exposed to DMF for six weeks. RESULTS: The intestinal tumor development of untreated female Min/hSULT mice was significantly lower compared to that of untreated Min females. No such effects of hSULTs were seen in males. DMF had a weak tumorigenic potential in the colon of female Min/hSULT mice, but not in males. Tumor development in Min mice was not affected. CONCLUSION: Overall, the tumorigenic potential of DMF in a metabolically competent mouse model was not convincing.